Bosulif Interactions
There are 561 drugs known to interact with Bosulif (bosutinib), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 169 are major, 390 are moderate, and 2 are minor.
- View all 561 medications that may interact with Bosulif
- View Bosulif alcohol/food interactions (1)
- View Bosulif disease interactions (6)
Most frequently checked interactions
View interaction reports for Bosulif (bosutinib) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- clopidogrel
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Esbriet (pirfenidone)
- furosemide
- gabapentin
- Gleevec (imatinib)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- Lasix (furosemide)
- levothyroxine
- metformin
- Metoprolol Tartrate (metoprolol)
- Mirapex (pramipexole)
- Norco (acetaminophen / hydrocodone)
- Ofev (nintedanib)
- ondansetron
- pantoprazole
- prednisone
- Rapamune (sirolimus)
- spironolactone
- tramadol
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
- Zofran (ondansetron)
Bosulif alcohol/food interactions
There is 1 alcohol/food interaction with Bosulif (bosutinib).
Bosulif disease interactions
There are 6 disease interactions with Bosulif (bosutinib) which include:
- cardiovascular disease
- fluid retention
- bone marrow suppression
- dehydration
- liver disease
- renal impairment
Report options
QR code containing a link to this page
More about Bosulif (bosutinib)
- Bosulif consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
